Rosenthal SA - Search Results

1

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer.

Hall WA, Paulson E, Davis BJ, Spratt DE, Morgan TM, Dearnaley D, Tree AC, Efstathiou JA, Harisinghani M, Jani AB, Buyyounouski MK, Pisansky TM, Tran PT, Karnes RJ, Chen RC, Cury FL, Michalski JM, Rosenthal SA, Koontz BF, Wong AC, Nguyen PL, Hope TA, Feng F, Sandler HM, Lawton CAF. Hall WA, et al. Among authors: rosenthal sa. Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):174-185. doi: 10.1016/j.ijrobp.2020.08.034. Epub 2020 Aug 27. Int J Radiat Oncol Biol Phys. 2021. PMID: 32861817 Free PMC article.

2

Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?

Curran WJ Jr, Herbert SH, Stafford PM, Sandler HM, Rosenthal SA, McKenna WG, Hughes E, Dougherty MJ, Keller S. Curran WJ Jr, et al. Among authors: rosenthal sa. Int J Radiat Oncol Biol Phys. 1992;24(1):25-30. doi: 10.1016/0360-3016(92)91016-g. Int J Radiat Oncol Biol Phys. 1992. PMID: 1324898

3

Adverse influence of younger age on outcome in patients with non-small cell lung carcinoma (NSCLC) treated with radiation therapy (RT) alone.

Herbert SH, Curran WJ Jr, Rosenthal SA, Stafford PM, McKenna WG, Hughes EN, Sandler HM. Herbert SH, et al. Among authors: rosenthal sa. Int J Radiat Oncol Biol Phys. 1992;24(1):37-42. doi: 10.1016/0360-3016(92)91018-i. Int J Radiat Oncol Biol Phys. 1992. PMID: 1324900 Clinical Trial.

4

Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease).

Rosenthal SA, Curran WJ Jr, Herbert SH, Hughes EN, Sandler HM, Stafford PM, McKenna WG. Rosenthal SA, et al. Cancer. 1992 Nov 15;70(10):2410-7. doi: 10.1002/1097-0142(19921115)70:10<2410::aid-cncr2820701006>3.0.co;2-4. Cancer. 1992. PMID: 1330280

5

Improved methods for determination of variability in patient positioning for radiation therapy using simulation and serial portal film measurements.

Rosenthal SA, Galvin JM, Goldwein JW, Smith AR, Blitzer PH. Rosenthal SA, et al. Int J Radiat Oncol Biol Phys. 1992;23(3):621-5. doi: 10.1016/0360-3016(92)90020-i. Int J Radiat Oncol Biol Phys. 1992. PMID: 1612962

6

Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate carcinoma.

Rosenthal SA, Roach M 3rd, Goldsmith BJ, Doggett EC, Pickett B, Yuo HS, Soffen EM, Stern RL, Ryu JK. Rosenthal SA, et al. Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):921-6. doi: 10.1016/0360-3016(93)90469-c. Int J Radiat Oncol Biol Phys. 1993. PMID: 8244824

7

Defining treatment margins for six field conformal irradiation of localized prostate cancer.

Roach M 3rd, Pickett B, Rosenthal SA, Verhey L, Phillips TL. Roach M 3rd, et al. Among authors: rosenthal sa. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):267-75. doi: 10.1016/0360-3016(94)90167-8. Int J Radiat Oncol Biol Phys. 1994. PMID: 8270451

8

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. Minsky BD, et al. Among authors: rosenthal sa. J Clin Oncol. 2002 Mar 1;20(5):1167-74. doi: 10.1200/JCO.2002.20.5.1167. J Clin Oncol. 2002. PMID: 11870157 Clinical Trial.

9

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU; Radiation Therapy Oncology Group. Hanks GE, et al. Among authors: rosenthal sa. J Clin Oncol. 2003 Nov 1;21(21):3972-8. doi: 10.1200/JCO.2003.11.023. J Clin Oncol. 2003. PMID: 14581419 Clinical Trial.

10

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02.

Valicenti RK, DeSilvio M, Hanks GE, Porter A, Brereton H, Rosenthal SA, Shipley WU, Sandler HM; Radiation Therapy Oncology Group Protocol 92-02. Valicenti RK, et al. Among authors: rosenthal sa. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1064-71. doi: 10.1016/j.ijrobp.2006.06.017. Epub 2006 Sep 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16979837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page